SIC
MEDP icon

SJS Investment Consulting’s Medpace MEDP Stock Holding History

SJS Investment Consulting’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.5K Buy
69
+12
+21% +$5.54K ﹤0.01% 579
2026
Q1 		$27.4K Sell
57
-15
-21% -$7.68K ﹤0.01% 580
2025
Q4 		$40.4K Buy
72
+68
+1,700% +$38.6K 0.01% 425
2025
Q3 		$2.06K Hold
4
– – ﹤0.01% 819
2025
Q2 		$1.26K Sell
4
-3
-43% -$901 ﹤0.01% 733
2025
Q1 		$2.13K Hold
7
– – ﹤0.01% 701
2024
Q4 		$2.33K Sell
7
-3
-30% -$1.02K ﹤0.01% 642
2024
Q3 		$3.34K Hold
10
– – ﹤0.01% 589
2024
Q2 		$4.12K Sell
10
-34
-77% -$13.5K ﹤0.01% 484
2024
Q1 		$17.8K Buy
44
+34
+340% +$12K ﹤0.01% 293
2023
Q4 		$3.07K Buy
10
+2
+25% +$540 ﹤0.01% 510
2023
Q3 		$1.94K Buy
8
+1
+14% +$256 ﹤0.01% 648
2023
Q2 		$1.68K Hold
7
– – ﹤0.01% 671
2023
Q1 		$1.32K Sell
7
-2
-22% -$414 ﹤0.01% 764
2022
Q4 		$1.91K Buy
9
+5
+125% +$999 ﹤0.01% 653
2022
Q3 		$1K Buy
+4
New +$638 ﹤0.01% 815
2022
Q1 		$0 Buy
+1
New +$165 ﹤0.01% 1094

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

SJS Investment Consulting's MEDP Position: Q2 2026 in Review

SJS Investment Consulting increased its Medpace (MEDP) stake by 21% in Q2 2026, buying an estimated $5.54K and bringing the position to 69 shares worth $36.5K. The position accounts for ﹤0.01% of the portfolio, ranked #579.

SJS Investment Consulting first reported a position in MEDP in Q1 2022 and has held it in 17 quarters since. The position peaked at $40.4K in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • SJS Investment Consulting held 69 shares of Medpace worth $36.5K as of Q2 2026.
  • SJS Investment Consulting bought 12 Medpace shares in Q2 2026, an estimated $5.54K.
  • Medpace made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #579 holding.
  • SJS Investment Consulting first reported a position in Medpace in Q1 2022 and has held it in 17 quarters since.
  • SJS Investment Consulting's Medpace position peaked at $40.4K in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.